ARCHIVES

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 11 | March 15, 1985

Download PDF Visit The Full Archive

Related Articles

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

November 23, 1974

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Broder Emerges As National Leader In ASCO Talk, Calls For Faster Reporting Of Clinical

June 2, 1989